tiprankstipranks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX

BioRestorative Therapies (BRTX) Income Statement

121 Followers

BioRestorative Therapies Income Statement

Last quarter (Q ), BioRestorative Therapies's total revenue was $30.70K, an increase of 5.86% from the same quarter last year. In Q, BioRestorative Therapies's net income was $-3.09M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 130.20K$ 119.80K$ 46.00K$ 77.00K$ 130.00K$ 111.00K
Cost of Revenue
------
Gross Profit
$ 130.20K$ 119.80K$ 46.00K---
Operating Expense
$ -4.18M$ 19.09M$ 26.35M$ 2.83M$ 8.56M$ 7.76M
Operating Income
$ -5.06M$ -18.97M$ -26.31M$ -2.75M$ -8.43M$ -7.65M
Net Non Operating Interest Income Expense
$ 337.97K$ 372.17K$ -1.82M$ -1.64M$ -5.14M$ -3.22M
Other Income Expense
$ -38.14K$ -107.09K$ 16.18M$ -6.88M$ -1.08M$ -1.65M
Pretax Income
$ -4.67M$ -18.49M$ -44.30M$ -11.27M$ -14.65M$ -12.52M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.67M$ -18.49M$ -44.30M$ -11.27M$ -14.65M$ -12.52M
Basic EPS
$ -4.12$ -5.11$ -37.30$ -15.75$ -2.64K$ -1.64
Diluted EPS
$ -2.94$ -5.11$ -37.30$ -15.75$ -2.64K$ -1.64
Basic Average Shares
$ 15.79M$ 3.62M$ 1.19M$ 715.54K$ 5.57K$ 7.63M
Diluted Average Shares
$ 12.17M$ 3.62M$ 1.19M$ 715.54K$ 5.57K$ 7.63M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -4.18M$ 19.09M$ 26.35M$ 2.83M$ 8.56M$ 7.76M
Net Income From Continuing And Discontinued Operation
$ -15.95M$ -18.50M$ -44.30M$ -11.27M$ -14.65M$ -12.52M
Normalized Income
$ -4.80M--$ -5.05M$ -15.44M$ -10.87M
Interest Expense
---$ 1.64M$ 5.14M$ 3.22M
EBIT
$ -5.02M$ -18.51M$ -42.49M$ -9.63M$ -9.51M$ -9.30M
EBITDA
$ -4.87M$ -18.39M$ -41.27M$ -9.51M$ -9.29M$ -9.06M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis